Medicines advice

Search Filters

Know what you're looking for?

Submission type

British National Formulary - Chapter

Pharmaceutical company

From

To

Advice

Accepted Not recommended Restricted Superseded Withdrawn Interim acceptance

Process

End of life/orphan Ultra orphan

Additional Details

Patient Access Scheme

Advanced Search

SMC ID	Date	Medicine	Submission Type	Indication
615/10	07/12/2015	gefitinib (Iressa)	Resubmission	the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of epidermal growth factor receptor tyrosine kinase (EGFR-TK).
615/10	10/05/2010	gefitinib (Iressa)	Full	Adult patients with locally advanced or metastatic nonsmall cell lung cancer (NSCLC)

No medicines have been found.